Research Topics
| Antonio Martin-MoralesSummaryAffiliation: Hospital Universitario Country: Spain Publications
|
Detail Information
Publications
Improvement in sexual quality of life of the female partner following vardenafil treatment of men with erectile dysfunction: a randomized, double-blind, placebo-controlled studyAntonio Martin-Morales
Department of Urology, Hospital Carlos Haya, Malaga, Spain
J Sex Med 8:2831-40. 2011..Erectile dysfunction (ED) impacts on both members of the couple. Female partners of men with ED are more likely to report reduced sexual quality of life than women whose partners do not have ED...- Vardenafil for the treatment of erectile dysfunction: an overview of the clinical evidenceAntonio Martin Morales
Department of Urology, Hospital Carlos Haya, Malaga, Spain
Clin Interv Aging 4:463-72. 2009..The evidence presented in this review supports the use of vardenafil as a first-line treatment for men with ED, including those with underlying conditions... - [Prevalence of ejaculatory dysfunction secondary to alpha-blocker therapy in patients with benign prostatic hyperplasia]A Martin-Morales
Servicio de Urologia, Hospital Carlos Haya, Malaga
Actas Urol Esp 32:705-12. 2008..Benign prostatic hyperplasia (BPH) is characterized by lower urinary tract symptoms (LUTS) that may cause ejaculatory disorders, although they could be also a consequence of alpha-blocker treatment... - Efficacy of vardenafil and influence on self-esteem and self-confidence in patients with severe erectile dysfunctionAntonio Martin-Morales
Department of Urology, Hospital Carlos Haya, Malaga, Spain
J Sex Med 4:440-7. 2007..To assess the efficacy of vardenafil in a population of Spanish men with erectile dysfunction (ED), its influence on patients' self-esteem and self-confidence, and its effect on their quality of life... - Therapeutic effectiveness and patient satisfaction after 6 months of treatment with tadalafil, sildenafil, and vardenafil: results from the erectile dysfunction observational study (EDOS)Antonio Martin-Morales
Hospital Carlos Haya, Servicio de Urologia, Malaga, Spain
Eur Urol 51:541-50; discussion 550. 2007..This observational study was conducted across Europe to assess health outcomes in men with erectile dysfunction (ED) who took tadalafil, sildenafil citrate (sildenafil), or vardenafil HCl (vardenafil) for 6 mo... - Specific aspects of erectile function in urology/andrologyA Martin-Morales
Department of Urology, Carlos Haya Hospital, Malaga, Spain
Int J Impot Res 16:S18-25. 2004.... - Effective treatment of erectile dysfunction with vardenafilAntonio Martin-Morales
Unidad de Andrologia, Complejo Hospitalario Carlos Haya, Malaga, Spain
Drugs Today (Barc) 39:51-9. 2003..Vardenafil, a new phosphodiesterase type 5 inhibitor, is an agent which has shown promise at each stage of development. The drug is currently in the third phase of clinical testing for the treatment of erectile dysfunction... - Diabetes impairs endothelium-dependent relaxation of human penile vascular tissues mediated by NO and EDHFJavier Angulo
Fundación para la Investigación y el Desarrollo en Andrología 28304, Madrid, Spain
Biochem Biophys Res Commun 312:1202-8. 2003.... - Treatment-seeking behavior of erectile dysfunction patients in Europe: Results of the Erectile Dysfunction Observational StudyJosep Maria Haro
Fundació Sant Joan de Déu, Esplugues de Llobregat, Spain
J Sex Med 3:530-40. 2006.... - Vardenafil improves satisfaction rates, depressive symptomatology, and self-confidence in a broad population of men with erectile dysfunctionDimitrios Hatzichristou
Department of Urology and Center for Sexual and Reproductive Health, Aristotle University of Thessaloniki, Greece
J Sex Med 2:109-16. 2005..Fixed-dose and flexible-dose studies have previously established the efficacy and tolerability of vardenafil...